BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12952982)

  • 41. RACK1, a new ADAM12 interacting protein. Contribution to liver fibrogenesis.
    Bourd-Boittin K; Le Pabic H; Bonnier D; L'Helgoualc'h A; Théret N
    J Biol Chem; 2008 Sep; 283(38):26000-9. PubMed ID: 18621736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ADAM12 is expressed in the tumour vasculature and mediates ectodomain shedding of several membrane-anchored endothelial proteins.
    Fröhlich C; Klitgaard M; Noer JB; Kotzsch A; Nehammer C; Kronqvist P; Berthelsen J; Blobel C; Kveiborg M; Albrechtsen R; Wewer UM
    Biochem J; 2013 May; 452(1):97-109. PubMed ID: 23458101
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure-function analysis of the diphtheria toxin receptor toxin binding site by site-directed mutagenesis.
    Mitamura T; Umata T; Nakano F; Shishido Y; Toyoda T; Itai A; Kimura H; Mekada E
    J Biol Chem; 1997 Oct; 272(43):27084-90. PubMed ID: 9341148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cloning and initial characterization of mouse meltrin beta and analysis of the expression of four metalloprotease-disintegrins in bone cells.
    Inoue D; Reid M; Lum L; Krätzschmar J; Weskamp G; Myung YM; Baron R; Blobel CP
    J Biol Chem; 1998 Feb; 273(7):4180-7. PubMed ID: 9461614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Roles of charged amino acid residues in the cytoplasmic domain of proHB-EGF.
    Nanba D; Toki F; Higashiyama S
    Biochem Biophys Res Commun; 2004 Jul; 320(2):376-82. PubMed ID: 15219838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ADAM12 localizes with c-Src to actin-rich structures at the cell periphery and regulates Src kinase activity.
    Stautz D; Sanjay A; Hansen MT; Albrechtsen R; Wewer UM; Kveiborg M
    Exp Cell Res; 2010 Jan; 316(1):55-67. PubMed ID: 19769962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells.
    Uchiyama-Tanaka Y; Matsubara H; Nozawa Y; Murasawa S; Mori Y; Kosaki A; Maruyama K; Masaki H; Shibasaki Y; Fujiyama S; Nose A; Iba O; Hasagawa T; Tateishi E; Higashiyama S; Iwasaka T
    Kidney Int; 2001 Dec; 60(6):2153-63. PubMed ID: 11737589
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of metalloprotease disintegrin ADAM12 in determination of quiescent reserve cells during myogenic differentiation in vitro.
    Cao Y; Zhao Z; Gruszczynska-Biegala J; Zolkiewska A
    Mol Cell Biol; 2003 Oct; 23(19):6725-38. PubMed ID: 12972593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insufficiency of pro-heparin-binding epidermal growth factor-like growth factor shedding enhances hypoxic cell death in H9c2 cardiomyoblasts via the activation of caspase-3 and c-Jun N-terminal kinase.
    Uetani T; Nakayama H; Okayama H; Okura T; Higaki J; Inoue H; Higashiyama S
    J Biol Chem; 2009 May; 284(18):12399-409. PubMed ID: 19193634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.
    Shah BH; Yesilkaya A; Olivares-Reyes JA; Chen HD; Hunyady L; Catt KJ
    Mol Endocrinol; 2004 Aug; 18(8):2035-48. PubMed ID: 15143154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein.
    Koike H; Tomioka S; Sorimachi H; Saido TC; Maruyama K; Okuyama A; Fujisawa-Sehara A; Ohno S; Suzuki K; Ishiura S
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):371-5. PubMed ID: 10510302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ectodomain shedding of HB-EGF: a potential target for cancer therapy.
    Miyazono K
    J Biochem; 2012 Jan; 151(1):1-3. PubMed ID: 21976708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of heparin-binding EGF-like growth factor expression during myogenesis. Activation of the gene by MyoD and localization of the transmembrane form of the protein on the myotube surface.
    Chen X; Raab G; Deutsch U; Zhang J; Ezzell RM; Klagsbrun M
    J Biol Chem; 1995 Aug; 270(31):18285-94. PubMed ID: 7629148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function.
    Xu D; Makkinje A; Kyriakis JM
    J Biol Chem; 2005 Jan; 280(4):2924-33. PubMed ID: 15556944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The metalloendopeptidase nardilysin (NRDc) is potently inhibited by heparin-binding epidermal growth factor-like growth factor (HB-EGF).
    Hospital V; Nishi E; Klagsbrun M; Cohen P; Seidah NG; Prat A
    Biochem J; 2002 Oct; 367(Pt 1):229-38. PubMed ID: 12095415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Notch increases the shedding of HB-EGF by ADAM12 to potentiate invadopodia formation in hypoxia.
    Díaz B; Yuen A; Iizuka S; Higashiyama S; Courtneidge SA
    J Cell Biol; 2013 Apr; 201(2):279-92. PubMed ID: 23589494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GIT1 mediates Src-dependent activation of phospholipase Cgamma by angiotensin II and epidermal growth factor.
    Haendeler J; Yin G; Hojo Y; Saito Y; Melaragno M; Yan C; Sharma VK; Heller M; Aebersold R; Berk BC
    J Biol Chem; 2003 Dec; 278(50):49936-44. PubMed ID: 14523024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropeptide-induced transactivation of a neuronal epidermal growth factor receptor is mediated by metalloprotease-dependent formation of heparin-binding epidermal growth factor.
    Shah BH; Farshori MP; Catt KJ
    J Biol Chem; 2004 Jan; 279(1):414-20. PubMed ID: 14573593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metalloprotease-disintegrin ADAM 12 interacts with alpha-actinin-1.
    Cao Y; Kang Q; Zolkiewska A
    Biochem J; 2001 Jul; 357(Pt 2):353-61. PubMed ID: 11439084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain.
    Miller MA; Moss ML; Powell G; Petrovich R; Edwards L; Meyer AS; Griffith LG; Lauffenburger DA
    Sci Rep; 2015 Oct; 5():15150. PubMed ID: 26477568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.